# The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip

> **NCT04303026** · PHASE3 · UNKNOWN · sponsor: **Vestre Viken Hospital Trust** · enrollment: 70 (estimated)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **DRUG:** Zoledronic Acid
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT04303026
- **Lead sponsor:** Vestre Viken Hospital Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-02
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303026, "The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04303026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*